Latest News

Image Credit: © Ralf - © Ralf - stock.adobe.com.
Phase 2/3 trial of new omicron-targeted vaccine shows efficacy in adolescents

October 3rd 2024

A single dose of the mRNA-1273.222 vaccine demonstrated strong immune responses against various omicron subvariants and showed a favorable safety profile compared to existing vaccines.

Antibiotics treatment duration for community-acquired pneumonia
Antibiotics treatment duration for community-acquired pneumonia

October 2nd 2024

Pertussis rates continue to rise in the United States
Pertussis rates continue to rise in the United States

October 1st 2024

Rana Hamdy, MD
Rana Hamdy, MD, talks diagnosis, treatment of community-acquired pneumonia

October 1st 2024

Tina Tan, MD
Tina Tan, MD, FAAP, FIDSA, FPIDS, previews big topics at the 2024 AAP National Conference & Exhibition

September 27th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.